CB
Climb Bio, Inc.
SEC filingBiotechnology · Wellesley Hills, MA
Amount raised$110.1Msold at filing
Total offering$110.1M
Investors in the raise22count reported to the SEC
FiledMay 4, 2026first sale Apr 29, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Aoife BrennanExecutive Officer, Director
Perrin WilsonExecutive Officer
Stephen ThomasDirector
Douglas WilliamsDirector
Susan AltschullerExecutive Officer
Kimberlee DrapkinDirector
Alexander (Bo) ComboDirector
Judith DunnDirector
Andrew LevinDirector
Executive officers, directors and promoters as listed on the Form D.